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INTRODUCTION 
 
 
Repair of a critical size bone defect still represents an issue in orthopedic surgery. Large 
segmental bone loss usually occurs after traumas or after bone tumor excisions. In such 
cases, the regeneration for new bone is impaired and surgery is crucial in order to fill the 
defect. Many different methods have been described up to now, all of them with positive 
aspects and drawbacks that strongly limit their routine use. The main issue is to fill the 
bony gap with a vital and integrated bone or bone like material, in order to overcome all 
the complications that these massive procedures carry with them such as infections, non 
healing, and multiple revision surgeries.  
Bone healing is a complex and articulated process of reconstruction of the bone tissue 
[1]. The vast majority of bone defects can heal spontaneously under suitable 
physiological environmental conditions due to the reparative ability of bone. However, 
new bone generation usually takes place slowly because of decreased blood supply to 
the fracture site and insufficiency of calcium and phosphorus to strengthen and harden 
new bone. In addition, large defects, also known as critical bone defects, may not heal 
spontaneously and can lead to nonunion due to the size of defects or unstable 
biomechanical properties, hostile wound environment, non optimal surgical procedure or 
execution, dismetabolic factors, hormones, nutrition, and stress forces [2,3].  
 
 
 
 
 
 
 
 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
CHAPTER 1 
LONG BONE DEFECTS 
 
 
1.1 CRITICAL SIZE DEFECT 
 
 
A segmental bone defect is labeled in experimental models as "critical" when its length 
is superior to the healing capabilities of that bone, by definition “the smallest size 
intraosseous wound in a particular bone and species of animal that will not heal 
spontaneously during the lifetime of the animal” [4]. Every bone has a different critical 
value, which differs according to several factors including soft tissue coverage, 
periosteal presence, age, specie, vascularization, mechanical load, fixation and so on. In 
animal models every bone in every different specie shows different values, which are 
mandatory to be kept into consideration when setting up a preclinical study in vivo. In 
fact, it is mandatory to create in experimental environment a defect which cannot 
spontaneously heal [5]. Usually for simplicity a critical size defect is considered a gap of 
a length exceeding 2-2.5 times the diameter of the affected bone [6]. 
Small size defects can be easily managed with different surgical options, usually by 
homologous non-vascularized cancellous bone grafting harvested from the iliac crest. 
In presence of a "critical size defect" in humans several surgical procedures have been 
developed over time, all of them with positive aspects and multiple drawbacks, with the 
result that unfortunately an optimal and safe procedure to treat these occurrences has not 
yet been developed.  
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1.2 BONE RESTORATION PROCEDURES 
 
 
Surgical options available for managing large defects are multiple, the most performed 
all over the world are bone substitutes, bone transport, non-vascularized grafts, allografts 
and autologous vascularized fibula pro tibia bone graft.  
Bone substitutes or synthetic graft biomaterials are commonly used, leading to a recent 
develop of a wide range of different substitutes biomaterials commercially available, 
made of naturally derived tissues, synthetic materials or metals (like the recently 
released trabecular titanium) [7-11].  
The ideal bone graft substitutes should be biocompatible, bioreabsorbable, 
osteoconductive, osteoinductive, structurally similar to native bone, easy to handle and 
ready to use. The bone substitutes have many positive aspects: they are virtually 
unlimited, so the amount of gap to be filled is never an issue, they can be shaped and 
contoured anatomically according to the specific necessities, and many of them proved 
to be able to be tolerated by the host cells. The stronger limitation is that the 
osteointegration is never complete, leading to a non viable material present in a skeletal 
segment: this highly increases the possibilities of infection, especially in 
immunocompromised patients (like many of the oncologic resected patients are). 
Autograft transplantation is the gold standard, as they encomprises all the three 
fundamental features for the bone regeneration: osteoinduction, osteoconduction and 
osteogenesis. Unfortunately, autografts cannot be used for massive bone loss (usually 
within 5 cms), as their use affects the donor site. The use of these graft, however, is 
associated with considerable negative side effects. Graft harvest leads to prolonged 
anesthetic periods and requires personnel. Sometime only an insufficient amounts of 
graft can be obtained, because the donor sites are limited. This technique commonly 
carries also the problem of donor site morbidity and the risk of infection [12]. Graft 
failures usually result from incomplete transplant integration, particularly in large 
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defects [12]. In addition, graft devitalization due to insufficient graft vascularisation and 
subsequent resorption processes can lead to decreased mechanical stability.  
Autologous vascularized bone grafting is currently one of the procedure of choice 
because of high osteogenic potential and resistance against reabsorption. The 
transplantation of vascularised autografts is time consuming and technically demanding: 
along with the extremely limited availability of donor sites, there is a huge difficulty in 
the surgical procedure which requires an highly skilled team, the necessity of 
microvascular techniques for vessels anastomosis [13]. The main advantage is that the 
bone can be transferred together with soft tissue to cover local soft tissue defect, leading 
to a higher rate of integration even in long bones with few soft tissue coverage (like 
tibia: in fact, the most executed procedure is autologous fibula pro tibia graft).  
Bone transport is another option for the management of very large bone defects: this 
technique has been introduced to avoid graft integration-related difficulties, and it is 
known as the “Ilizarov technique”. It is performed with an osteotomy of bone combined 
with distraction to stimulate bone formation. This procedure has been applied 
successfully to treat large bone defects, infected non-unions, and limb length 
discrepancy [14]. However, Ilizarov technique is difficult accepted by the patients 
because of the massive hardware, the necessary compliance of the long lasting post op 
protocol, frequent clinical and radiological follow ups, and recurrent pin track infections. 
The procedure has a very high overall complication rate, but it is still one of the mostly 
performed procedures in diaphyseal loss in long bones of lower limbs. 
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1.3 ALLOGRAFT 
 
 
In the last decade this allograft technique has been widely used for several orthopaedics 
diseases: in the US more than 5 million bone tissue allografts have been transplanted in 
the last 10 yrs [15], especially to replace bone and joints lost after metallic implants 
removal and bone tumors excision [16-18]. Tissue banks use a different technique in 
bone allograft excision and preparation, and the debate on what should be the better 
protocol is still ongoing. Donors should undergo a full screening histories (from medical 
records or relative interviews) and physicals examination, along with a screening 
laboratory tests for transmissible diseases. Usually the grafts are explanted from the 
donor with aseptic technique, in a sterile operating room environment after the donor has 
been washed properly and the skin covered with antiseptic solution.  This is usually 
performed as soon as possible after death of the donor, with general limits of 24 hours if 
the body has been refrigerated or 12 hours if it has not been refrigerated. In some cases 
the procurement would be performed immediately after the harvesting of visceral 
organs. The donor’s body is draped in a similar fashion to that used during surgery. 
Cultures are obtained usually twice on each harvested tissue. Various solutions, such as 
antibiotics, surfactants, and alcohols, may be used to prepare the allograft tissue. The 
method of secondary sterilization, also known as terminal sterilization, is used in the 
cases in which the allografts are not obtained in an aseptic technique [19].  
Bone allografting offers the advantage of allowing the surgeon to place a graft of the 
same anatomic location, with good mechanical and osteoconductive properties. 
Furthermore, this grafts still contain osteoinductive factors, which give the advantage of 
a boost to osteoinduction properties. Regarding immunogenicity, bone and tissue 
allograft tissues can theoretically elicit immune responses in the hosts, mediated via 
class I and II major histocompatibility complex (MHC) antigens. However, because cell 
death occurs with tissue processing, the magnitude of immune reaction is really low, 
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sometimes showing itself as graft reabsorption over time and usually not with the 
commonly observed rejection processes with soft tissues or organs [6,20-23]. 
Although autografts are the current gold standard treatment for bone defect regeneration 
[12], it still has the main disadvantages in the limitation in donor supply [ 24].  
 
 
 
1.4 INNOVATIVE PERSPECTIVE 
 
In order to overcome the major drawbacks of the aforementioned options, the idea to 
blend bone graft substitutes and the concept of tissue engineering is gaining more and 
more interest. Several studies in literature reported the ability of bone marrow stem cells 
(BMSCs) to promote neoangiogenesis. Neo-vascularization is the crucial point in order 
to provide a regenerative potential to an implanted graft, and for these purpose 
mesenchymal stem cells are needed. A recently developed technique, arthroscopic bone 
marrow stem cells (BMSCs) transplantation (“one-step” Technique), involves the 
harvesting of bone marrow from posterior iliac crest, its concentration directly in 
operating room, thus without the need of cells' expansion, and the successive 
transplantation of the cells onto a scaffold in the affected area [25-27]. 
The use of concentrated bone marrow derived cells has been gaining successful results 
since it is possible to transplant not only mesenchymal stem cells but also accessory 
cells that support stem cells’ proliferation and differentiation by producing several 
growth factors. The capability of bone marrow-derived cells to differentiate into both 
chondral and osseous lineages, thus supporting the hypothesis that in vivo bone marrow-
derived cells may be able to fill both chondral and osseus defects associated with the 
release of trophic molecules, has already been demonstrated [28-33]. 
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CHAPTER 2 
ANGIOGENESIS AND OSTEOGENESIS 
 
 
 
2.1 THE ROLE OF ANGIOGENESIS IN BONE FORMATION AND FRACTURE 
HEALING 
 
 
 
Osseous tissue is the major structural and supportive connective tissue of the body. Bone 
is composed of a matrix containing abundant collagen fibers which impart strength, 
some flex, and resistance to twisting or torsional forces, and of a cement-like ground 
substance called hydroxyapatite, a mineral complex of calcium phosphate salts makes 
bone highly resistant to compression forces. 
There are two main kinds of bone: trabecular bone, also known as spongy or cancellus 
bone, and cortical bone also called compact or hard bone. The first gives supporting 
strength to the end of weight-bearing bone, while cortical bone is on the outside and 
forms the shaft of the long bones [34]. Cortical bone is dense and solid and surrounds the 
marrow space, whereas trabecular bone is composed of a honeycomb-like network of 
trabecular plates and rods interspersed in the bone marrow compartment. Both bone 
types are composed of osteons. Osteon, also named haversian system, is the fundamental 
functional unit of bone [34]. The adult human skeleton is composed of 80% cortical 
bone and 20% trabecular bone overall. Ratios of cortical to trabecular bone are different 
depending on skeleton sites or bone types [35]. 
Cortical bone has an outer periosteal surface (periosteum) and inner endosteal surface 
(endosteum). Both p and periosteum  and endosteum are important for appositional 
growth and fracture repair (Fig. 1a). 
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Despite its inert appearance, bone is a highly dynamic organ continuously resorbed and 
neoformed. It is a mineralized connective tissue that exhibits four types of cells: 
osteocytes, osteoblasts, osteogenic cells and osteoclasts. Osteoclasts are large 
multinuclear cells associated with the resorption of bone, osteoblasts are mononucleate 
cells from which bone develops, while osteocytes are a mature bone cell type involved 
in the maintenance of bone tissue and act as mechanosensors. Osteogenic cells are the 
osteoblast precursors and play an important role in osteogenesis during development and 
growth and in bone fracture repair in adulthood (Fig. 1b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 a  Bone structure and bone cell types. 
Long bones contain two distinct morphological types of layers. Periosteum is a layer of vascular, 
innervated, dense connective tissue surrounding the non-articular surfaces of bone. The endosteum is a 
thin layer of connective tissue that lines the inside of the marrow cavity and any canals passing through 
the compact bone. Both the periosteum and the endosteum membranes contain osteogenic cells. During 
growth or following injury, osteogenic cells can differentiate into bone-formin g osteoblasts or osteocytes. 
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Figure 1 b Bone structure and bone cell types. 
Four types of cells are found within bone tissue. Osteogenic cells are undifferentiated and develop into 
osteoblasts. When osteoblasts get trapped within the calcified matrix, their structure and function 
changes; they become osteocytes. Osteoclasts develop from monocytes and macrophages and differ in 
appearance from other bone cells. 
Source: Boundless. “Cell Types in Bones.” Boundless Biology. Boundless, 08 Jan. 2016. Retrieved 11 
May. 2016 from https://www.boundless.com/biology/textbooks/boundless-biology-textbook/the-
musculoskeletal-system-38/bone-216/cell-types-in-bones-816-12058/ 
 
 
 
Bone formation (osteogenesis) initiates with the process of cellular condensation, where 
dispersed mesenchymal cells migrate and proliferate [36] and subsequent bone 
development occurs in two different mechanisms: endochondral ossification (the 
formation of a cartilage template and its replacement by bone) and intramembranous 
ossification (direct differentiation of mesenchymal stem cells into osteoblasts), both 
processes involve the transformation of a pre-existing mesenchymal cells into bone 
tissue, and it take place in close proximity to vascular ingrowth.  
The first type of ossification occurs during embryonic development and is involved in 
the development of flat bones in the cranium, various facial bones, parts of the mandible 
and clavicle and the addition of new bone to the shafts of most other bones. In contrast, 
bones of load bearing joints form by endochondral formation (Fig. 2). 
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Figure 2    a schematic diagram of endochondral bone stages  
 
(a) Mesenchymal cells condense and differentiate into chondrocytes forming an avascular cartilage 
model of the future bone. (b) At the centre of condensation the chondrocytes cease proliferating and 
become hypertrophic. (c) Perichondral cells adjacent to the hypertrophic chondrocytes differentiate 
into osteoblasts forming a bone collar. The hypertrophic cartilage regulates the formation of 
mineralised matrix; the release of angiogenic factors to attract blood vessels and undergoes 
apoptosis. (d) The coordination of osteoblasts and vascular invasion form the primary spongiosa. 
The chondrocytes continue to proliferate with concomitant vascularization resulting in a coordinated 
process that lengthens the bone. Osteoblasts of the bone collar will eventually form cortical bone; 
while osteoblasts precursors located in the primary spongiosa will eventually form trabecular bone. 
(e) At the ends of the bone, secondary ossification centres develop through cycles of chondrocyte 
hypertrophy, vascular invasion and osteoblast activity. Columns of proliferating chondrocytes form 
in the growth plate beneath the secondary ossification centre. (f) Finally, expansion of stromal cells 
and hematopoietic marrow starts to take place in the marrow space. 
 From Marks and Hermey, 1996 
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Bone is a highly vascularized tissue reliant on the close spatial and temporal connection 
between blood vessels and bone cells to maintain skeletal integrity. During bone 
development, as well as, in the repair process tissue vascularisation is fundamental. The 
process of new vessels formation is called angiogenesis and occurs in the earlier stages 
of bone formation favouring growth factors import, mineral deposition and 
mesenchymal cells localization. There are a number of factors involved in 
neoangiogenesis but the main protagonists are Vascular Endothelial Growth Factors 
(VEGFs). VEGFs and their corresponding receptors are the key regulator s in the 
cascade of cellular e molecular events lead to the development of the vascular system, 
including vasculogenesis, angiogenesis and in the lymphatic vascular system formation 
[37]. It is already known the pivotal role of VEGF in the in skeletal growth [38] and 
repair [39]. The endothelium plays a significant role in the maintenance of homeostasis 
of the bone tissue providing growth factors, chemokines, cytokines and regulating 
movement of molecules and cells. The latter is very important for coordination signals 
forwarding in recruiting of cells or factors towards specific skeleton sites.  This event 
cascade occurs during bone remodeling, in response to trauma or in pathophysiological 
conditions (rheumatoid arthritis and osteoarthritis) [40]. 
In the wound healing, as well as bone fracture repair, vascular system is closely 
involved. Indeed, bone healing is a complex biological process that follows specific 
regenerative steps also involving different biochemical events.  
The trauma gives rise to an inflammatory response which is necessary for the healing to 
progress. The response causes the hematoma to coagulate in between and around the 
fracture edges and within the medullar canal forming a template for callus formation. 
The initial proinflammatory response involves secretion of tumor necrosis factor-α 
(TNF-α), interleukin-1 (IL-1), IL-6, IL-11 and IL-18. These factors recruit inflammatory 
cells and promote angiogenesis through the vascular endothelial growth factor (VEGF) 
production [41]. During this acute phase mesenchymal stem cells are recruited from 
bone marrow and surrounding soft tissues starting the regenerative stage where BMPs 
seem to have an important role. Adjacent to the distal and proximal ends of the fracture 
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both intramembranous and endochondral ossification give rise to the formation of a 
cartilaginous callus which later undergoes mineralization generating a hard callus [42]. 
In order to bone regeneration completing, the primary soft cartilaginous callus needs to 
be resorbed and replaced by a hard bony callus. For bone remodelling to be successful, 
an adequate blood supply and a gradual increase in mechanical stability is crucial [43] 
(Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3   Steps of bone fracture healing: (a) A fracture hematoma formation. (b) Internal and 
external calli formation. (c) Cartilage of the calli is replaced by trabecular bone. (d) Remodeling 
occurs. Source: http://philschatz.com/anatomy-book/contents/m46342.html 
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2.2 REGENERATIVE MEDICINE: NEW PERSPECTIVES IN BONE 
REGENERATION 
 
 
 
The repair of large bone defects remains a major orthopaedic challenge and the actual 
surgical procedures have not brought good long-time results and significant clinical 
outcomes. There is a plethora of different strategies to augment the impaired or 
“insufficient” bone-regeneration process. 
Autologous bone graft is considered the gold standard but the need of bone harvesting 
improves site morbidity, for this reason allograft implantation bypass this problem 
nevertheless the integration ability and clinical outcomes are poorer than gold standard 
procedure. Several synthetic or biologic scaffold constructs have been employed in the 
development of tissue-engineered bone in these years but it is clear that needs more 
components to obtain and maintain the tissue. 
Local strategies in terms of use of osteoinductive stimuli (bone marrow concentrate 
(BMC), platelet rich plasma (PRP), bone morphogenic proteins (BMPs) and growth 
factors combined with mesenchymal stem cells (from Bone marrow or other tissues, 
including muscle, periosteum, adipose tissue, vascular pericytes, dermis, and peripheral 
blood) have been largely investigated [44], more recently and, still under investigation, 
they are the “systemic approache” for the enhancement of bone repair, including growth 
hormones and parathyroid hormone (PTH) administration [45], and gene therapy [46] in 
an effort to overcome the limitations of the current methods to bone regeneration. 
Tissue engineered bone constructs, therefore, should ideally have mechanical properties 
similar to native bone during the entire process of tissue repair and regeneration, 
especially when constructs are to be implanted in load-bearing sites.  
Biological guidelines for bone tissue regeneration involve the interplay of four critical 
elements, namely: (1) osteoinductive growth factors (induce differentiation of stem cells 
to osteoblasts); (2) stem cells that respond to osteoinductive signals (osteogenic); (3) a 
scaffold that supports cellular attachment, proliferation, and ingrowth (osteoconductive 
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matrix) and (4) for graft host tissue functional integration and survival vascularization is 
an essential pre-requisite [47]. 
 
The development of a microvasculature and microcirculation is critical for the 
homeostasis and regeneration of living bone, without which, the tissue would simply 
degenerate and die. Vascular supply is necessary to assure efficient gas and nutrition 
exchange with all cells within the tissue but also for releasing of vascular growth factor 
(VSF) at the bone fracture site to induce repair process [48].  
 
Currently, there are several approaches being utilized in order to vascularize bone grafts, 
and generally one or combination of three major principles can be followed. The main 
techniques are: 1) Bone grafts can be implanted into environments rich in vascular 
supply (subcutaneous, intramuscular, or intraperitoneal sites), where the constructs can 
be invaded with new vascular networks at their surfaces (In vivo pre-vascularization);  
2) local delivery of angiogenic growth factors (VEGF, PDGF, and FGF). The 
combination of osteogenic (BMP-4) and angiogenic (VEGF) factors together with bone 
marrow stromal cells promoted bone formation at an ectopic site [49]. The combined 
delivery of cells, osteogenic and angiogenic factors resulted in a significant increase in 
the quantity of regenerated bone compared with any factor alone or any two associated 
factors; 
3) vascularization of tissue engineered bone grafts seeding a co-culture of endothelial 
and osteogenic cells into the bone constructs engineered in vitro [47] (Fig. 4). 
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Figure 4  Approaches to Vascularizing Engineered Bone Scaffolds 
  
Source: Fröhlich et al, Curr Stem Cell Res Ther. 2008. 
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CHAPTER 3 
EXPERIMENTAL PROJECT 
 
 
 
3.1 AIM OF THE STUDY 
 
 
 
Aim of the present study is to investigate the results of an innovative technique based on 
a bio-composite made of allografts, BMSCs and vascular supplement for the 
reconstruction of large bone defects. This technique has been developed in order to give 
answer to all that complex and difficult situations that lead to a long bone critical size 
defect, where the surgical procedures at the state of the art are not satisfying.  In order to 
pursuit this goal an animal model has been set up taking into account the type of tissue 
to be repaired, the amount of bone loss to be created, the state of the art knowledges in 
biology and regenerative medicine.  
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CHAPTER 4 
MATERIALS AND METHODS 
 
 
It was decided that for this aim the rabbits would have been the most appropriate animal 
model, in particular the radius bone. Rabbit in fact is one of the most commonly used 
animal models, and it ranks first among all the animals used for musculoskeletal 
research. It was reported that there were similarities in bone mineral density and the 
fracture toughness of mid-diaphyseal bone between rabbits and human. Besides that, in 
comparison with other species, such as primates or some rodents, rabbit has faster 
skeletal change and bone turnover. In particular, the anterior limb of the rabbit is a low 
weight bearing limb and has an extremely limited pronation-supination movement, 
which constitutes an optimal characteristic to test bone substitute since there's no 
necessity of strong hardware to fix the graft to the healthy bone. Furthermore, rabbits are 
easily available, and easy to house and handle.   
The study was conducted in compliance with Italian and European laws concerning 
animal experiments. The research protocol was approved by the Ethics Committee of 
'Rizzoli Orthopaedic Institute and authorized by Italian Ministry of Health according to 
Legislative Decree 116/92 and was performed according to Legislative Decree 26/2014. 
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4.1 SURGICAL PROCEDURE 
 
 
A total of 24 HYCR adult rabbits (Harlan Laboratories s.r.l., Udine, Italy), weight 
3.0±0.4kg, were employed and housed, in accordance with the Recommendations 
2007/526/CE, at the following environmental conditions: individual cages, standard diet 
with long-term maintenance pelleted feed (Mucedola s.r.l., Settimo Milanese, Italy) and 
water ad libitum, temperature 20.5 ± 0.5 °C and relative humidity 55 ± 10%. After the 
period of quarantine, the animals were randomized in the experimental groups as 
following (Fig.5): 
The 24 rabbits have been divided into 2 groups: 
− Group 1 (#12): allogenic bone graft (left radius) / allogenic bone graft + vascular 
pedicle + autologous bone marrow concentrate (right radius) 
− Group 2 (#12): sham operated (left radius)/ allogenic bone graft + vascular 
pedicle (right radius) 
 
Figure 5 Experimental design of the study 
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For each group, 3 experimental times have been set up: 8, 4 and 2 weeks (4 animals for 
each time). The bone used as graft was previously collected from an uncorrelated study. 
After premedication with intramuscular injection of 44 mg/kg ketamine (Imalgene 1000, 
Merial Italy SpA, Assago-Milano, Italy) and 3 mg/kg xylazine (Rompun 25 ml, Bayer 
SpA, Italy), general anesthesia was induced and maintained with the administration of a 
gaseous mixture (O2/air: 60%/ 40%), in spontaneous ventilation by administration of 
sevoflurane 2-3% (Sevoflurane, Baxter SpA, Rome, Italy). 
The surgical procedure was performed after bilateral anterior leg shaving and washing 
with antiseptic solution of the rabbits.  
For the rabbits in which the bone marrow was to be added to the procedure, bilateral 
iliac crest region of the rabbit was shaved and cleaned. An initial 5cc of whole bone 
marrow was harvested from the posterior iliac crest with the addition of anticoagulant 
solution and sent to the lab for concentration; the bone marrow was stratified on gradient 
of density (Ficoll) and the obtained mononuclear cell fraction washed and returned to 
operating room.  
A longitudinal skin incision was then performed in the anterior leg of the rabbit in the 
antero-medial aspect, in the area between radius and ulna. Muscles were retracted and 
the median vascular bundle was isolated and protected. The midshaft of the radius was 
then exposed, and a 1,5 cm segmental defect (Fig. 6) was made over the midshaft of the 
rabbit radius using an electric saw, and periosteum surrounding the defect was 
completely removed.  
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Figure 6  1.5 cm of the radial shaft are marked and subsequently removed 
 
 
In right radius of one experimental group this constituted the control group and the 
defect was not filled with any graft. The muscular layer, the subcutaneous tissue and the 
skin were sutured with appropriate stitches, medicated and dressed.  
In right radius of the other experimental group the bony gap was filled with a cylindric 
allograft, countured from a rabbit radius previously explanted from animals which has 
undergone another experimental protocol and stored at -80°, as a normal procedure for 
human bone allograft. The graft was shaped in order to fill the gap with press fit 
technique, and was secured to the original bone with two 2.0 polysorb stitches or two 
metallic wire circlages.  
In left radius of one experimental group the gap was filled with an allograft with a 
vascular deviation inside: the cylindrical graft was shaped with an electric burr, 
performing a longitudinal complete incision on one side opening longitudinally the graft 
canal. This permitted to the median vascular bundle to be positioned inside the graft 
without a microsurgical anastomosis. In order to not compress the vascular bundle 
entering and exiting from the graft, on the other side of the graft two small longitudinal 
incisions were performed (Fig. 7).  
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Figure 7  The graft to be inserted is shaped in order to fit the vascular bundle at its inside without 
compressing it. 
 
 
 
32 
 
The graft with the vascular bundle at its inside was then press-fit positioned into the 
defect and fixed as described above, taking care not to overstretch the bundle and double 
checking that the vessels were not compressed (Fig. 8,9). 
 
 
 
 
 
Figure 8   The median vascular bundle is inserted in the allograft from the longitudinal opening 
 
 
Figure 9   The allograft with the vascular bundle is than press-fit positioned in the bony gap and 
subsequently secured with suture or metallic circlages. 
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In the other group of left radius, a biomaterial was positioned around the described 
construct: a scaffold made of equine type I collagen (BIOPAD®, Novagenit, Trento-
Italy) loaded with 1 ml of autologous bone marrow previously harvested and 
concentrated. At this point the muscular layer was closed covering the whole construct, 
and a standard closure was performed as previously described (Fig. 10). 
 
 
 
 
Figure 10   The BIOPAD with the bone marrow concentrate is than positioned onto the graft, wrapping 
the entire construct. The muscular layer is than sutured onto the implant and a standard closure is 
performed. 
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4.2 POSTOPERATIVE CARE  
 
Postsurgical rabbits were housed individually cage, with food and water ad libitum. 
Intramuscular administrations of antibiotics Flumequine (Flumexil, Fatro SpA, Bologna-
Italy) for 4 days and analgesics, 80 mg/Kg of sodium metamizole (Farmolisina, Ceva 
SpA, Monza-Italy) and a Fentanyl transdermal patches was applied in the external 
surface of the hear for 3 days (Matrifen 25µg/72h, Grunenthal Italia Srl). The rabbits 
were regularly monitored for signs of infection and instability of fixations. Dressing was 
changed whenever necessary. 
At the end of experimental time, rabbits were kept in deep sedation (ketamine and 
xylazine i.m.) to allow bone marrow harvesting from the iliac crest and pharmacological 
euthanasia through intravenous injection of 1 ml of Tanax (Hoechst AG, Franfurt-am-
Main, Germany). After macroscopic examination of the bone and surrounding soft 
tissue, the radius segments were removed and an overall macroscopic assessment of the 
tissue state was made (presence of hematomas, edema, inflammatory reactions or 
necrosis). 
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4.3 CELL CULTURES, RABBIT BONE MESENCHYMAL STEM CELLS (rBMSC) 
CHARACTERIZATION AND SCAFFOLD SEEDING 
 
 
4.3.1 rBMSC isolation and expansion 
 
Rabbit bone marrow was harvested by iliac crest from all the animals. After 1:4 dilutions 
in phosphate buffer saline (PBS), the sample was stratified on density gradient medium 
(Ficoll-Paque, density 1.077g/ml, Sigma-Aldrich, MO, USA), to obtain mononuclear 
cells (MNCs).They were then twice washed with PBS, counted in Neubauer chamber 
and seeded in flasks at a density of approximately 4x105 cells/cm2 in a basal medium 
(BM) composed by Dulbecco’s Modified Eagles Medium (DMEM, Sigma-Aldrich, 
St.Louis, MO, USA), 10% Fetal Bovine Serum (FBS, Lonza, Verviers, Belgium), 
100U/ml penicillin, 100mg/ml streptomycin (Gibco, Life Technologies, Carlsbad, CA, 
USA) and 5 µg/ml plasmocin (Invivogen, San Diego, CA, USA). Cultures were 
maintained at 37°C, in a 5% CO2 /air humidified atmosphere to select rBMSC by means 
of adhesion to plastic substrate and expanded until the 2th passage. Then, they were 
detached with 0.05% Trypsin/EDTA and used for all the experiments. 
 
4.3.2 rBMSCcharacterization: trilineages differentiation 
 
For adipogenic differentiation, the cells were seeded at the density of 5x103 cell/cm2in 
24 well plates and maintained up to 2 weeks in adipogenic medium (AM), consisting of 
BM added with insulin (10g/ml), isobutylmethylxanthine (500µM), 
indomethacin(100µM), dexamethasone (1µM). Adipogenic differentiation was assessed 
using an Oil Red O stain as indicator of intracellular lipid accumulation. Prior to 
staining, the cells were fixed for 10 min at room temperature (RT) in 4% 
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paraformaldehyde, extensively washed with deionized water, and incubated at RT for 5 
min in 60% isopropanol solution. After washing with deionized water, a 1.8% Oil Red 
solution in 60% isopropanol was added to culture for 15 min at RT. At the end of 
incubation, significant imagines were captured to appreciate red lipid vacuoles by using 
Eclipse TiU inverted microscope (NIKON Europe BV, NITAL SpA, Milan, Italy). 
For chondrogenic differentiation, 2.5x105 cells per tube (Sarstedt, Nümbrecht, Germany) 
were pelleted in micromasses (10 minutes, 160g) and kept in 1 ml of chondrogenic 
medium (CM): differentiation basal medium-chondrogenic (POIETICS, LONZA, 
Verviers, Belgium), added with suitable supplements and 10% FBS (POIETICS, 
LONZA, Verviers, Belgium). The micromasses, which represent the recommended 3D-
system to induce a correct chondrocyte differentiation, were cultured for a month. 
Micromasses as control were set up in BM. 
At experimental endpoint, chondrogenesis was confirmed using histological staining and 
Glicosaminoglycan (GAG) quantification. The micromasses were in addition analyzed 
for extracellular chondrogenic matrix formation in term of glycosaminoglycans (GAGs) 
synthesis. The assay was performed by measuring the reaction between GAGs and 1,9-
dimethylmethylene blue (DMMB) reagent (Sigma–Aldrich). The samples were digested 
overnight with 0.3mg/ml papain solution in a phosphate/EDTA buffer, pH 6.5, at 65°C, 
added with DMMB solution to develope a GAG-dye complex, and 
spectrophotometrically read at 525nm (iMARK Microplate Reader, Bio-Rad). Total 
GAGs content was extrapolated referring to a standard curve set up with shark 
chondroitin sulfate (Sigma-Aldrich). 
For osteogenic differentiation, the cells were seeded at the density of 5x103 cell/cm2in 
24 well plates and maintained up 14 days in osteogenic medium (OM) consisting of BM 
added with 50µg/ml ascorbic acid 2P, 7 mM β-glicerophosphate and 10-7M 
dexamethasone (Sigma Aldrich). 
To quantify the osteogenic differentiation, intracellular alkaline phosphatase (ALP) 
activity was evaluated by reading the kinetics of p-nitrophenyl phosphate hydrolysis in 
the presence of ALPase. The developed color was spectrophotometrically read at 405 
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nm (iMARK Microplate Reader, Bio-Rad) and the concentration of the 4-nitrophenol 
product was calculated referring to a standard curve. All the chemicals were purchased 
from Sigma-Aldrich. 
In addition, to observe and quantify the Ca/P deposition, cells were fixed with 4% 
paraformaldehyde for 15 min at RT and stained for 1 hour with a 2% ARS solution, pH 
4.2. The cultures were then rinsed with distilled water until clear. Representative images 
were captured using Eclipse TiU inverted microscope at 10x magnification. ARS was 
subsequently eluted using a solution of 10% w/v cetylpyridinium chloride in sodium 
phosphate 10 mM, pH 7 (Sigma-Aldrich). The absorbance of the resulting solution was 
measured at 570 nm (iMARK Microplate Reader, Bio-Rad, Hercules, CA) and ARS 
concentration was obtained by referring to a standard curve [50]. 
All experiments were performed by setting up both the conditions of differentiation and 
control, in three independent replicates. 
 
 
4.3.3 Gene expression analysis 
 
 
At 24 hours, 1 week and 2 weeks, total RNA was extracted from the cultures 
differentiating toward osteoblast lineage (and relative controls) with a phenol-
chloroform method using Trizol reagent (Life Technologies) and reverse transcribed 
using the Superscript Vilo cDNA synthesis kit (Life Technologies), following the 
manufacturers’ instructions. cDNA was quantified by using Quant-iT Pico-Green 
dsDNA assay kit and diluted to the final concentration of 5 ng/μl.  
Quantitative polymerase chain reaction (qPCR) analysis was performed using the 
QuantiTect SYBR green PCR kit (Qiagen, Hilden, Germany) in a Light Cycler 2.0 
Instrument (Roche Diagnostics). 
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The protocol included a denaturation at 95°C for 15 minutes, 30-50 cycles of 
amplification (95°C for 20s, 55°C for 20s and 72°C for 20s) and a melting curve 
analysis to check for amplicon specificity. Ten nanograms of each sample were tested in 
duplicate. The mean threshold cycle was used for the calculation of relative expression 
using the 2-ΔΔCt method, against GAPDH as the reference gene and using the CRL 
condition at 24h as the calibrator.  
 
 
4.3.4 Scaffold seeding 
 
 
The same material employed for in vivo implants has been tested in vitro for cell 
adhesion and viability. Briefly, BIOPAD® scaffold was placed in 24-well plates, 
prewetted with OM for 1 hour and seeded dropwise with 2x105/cm2rBMSC suspended 
in 30µl of medium. The constructs were then incubated for 3h to allow cell attachment 
and scaffold colonization, before adding the remaining OM volume.  
After 24 hours, 7 and 14days the cell viability was observed by the fluorescent labeling 
LIVE/DEAD® assay (Molecular Probes, Eugene, OR, USA), according to the 
manufacturer’s instructions. Samples were visualized using Eclipse TiU inverted 
microscope equipped with an epiﬂuorescence setup: excitation/emission setting of 
488/530 nm to detect green ﬂuorescence (live cells) and 530/580 nm to detect red 
fluorescence (dead cells). 
At the same time points the constructs were observed also by histology (see below). 
Three replicates of constructs were set up, using as many bone marrow samples. 
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4.3.5 Cocultures 
 
 
Primary rabbit vein endothelial cells (rEC, Cell Biologics, Chicago, USA) were seeded 
on the bottom of 12 well multiplate at the density of 1.5x104cell/cm2after well 
precoating set up with gelatin. Separately, rabbit rBMSC were seeded dropwise on 
BIOPAD® scaffold at the density of 2x105 cell/cm2 after 2 hours of scaffold prewetting 
in complete medium. Each BIOPAD® scaffold were placed inside a cell culture insert 
(Millicel 0.4µm pore-size, PCF, 12 mm diameter, Millipore, Tulagreen Carrigtwohill, 
Co. Cork, Ireland). Twenty-four hours after seedings, to allow endothelial cells adhesion 
to plastic substrate and rBMSC to the scaffold, co-cultures were set-up by transferring 
the culture inserts in the wells containing the rEC. The medium was a mixture of OM 
and complete medium EBM-2 (Clonetics LONZA, Walkersville, MD, USA) and was 
replaced twice a week. In the same multiplates, also single cultures: rBMSC on 
BIOPAD scaffold, endothelial cells alone, were set up. All cultures were maintained 
until 14 days. After 24 hours, 7 and 14days the cell viability was observed by the 
fluorescent labeling LIVE/DEAD® assay as described in the previous section.  
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4.4 X-RAY AND MICROTOMOGRAPHY 
 
 
Standard 2 poses X rays of the operated forearms were taken at the sacrifice times. The 
retrieved forearm bone samples were scanned with the high-resolution microtomography 
system Skyscan 1176 (Bruker Micro-CT, Belgium) using a nominal resolution of 35 µm. 
The source voltage was set on50kV with a current of 500μA and an aluminum filter 
0.5mm thick was interposed between the x-ray source and the sample. Each sample was 
rotated until 180° with a rotation step of 0.5° and a frame averaging of 2. The images 
obtained from acquisition were later reconstructed by the software NRecon (version 
1.6.10) with corrections for alignment, depended on acquisition, beam hardening and 
ring artifact reduction. The images resulted jpg images had 1000X1000 pixels with a 
pixel size of 35 μm.  
Quantitative 3D analyses were carried out with CTAn software (version 1.15.4, Bruker 
Micro-CT, Belgium) in a cubic Volume of Interest (VOI) of 20x20x20 mm defined in 
each samples in order to keep the defect /graft in the central position. 
The following morphological parameters were evaluated: 
- Callus density, Cl.V/TV (%); defined as the ratio between Callus Volume in mm3 
(Cl.V) including voids and the defined VOI (TV) in mm3; 
- Callus Index, Cl.Ind (%); defined as: 
 
where Cl.V is the Callus Volume as defined above and Cl.Vtissue is the Callus Tissue 
Volume in mm3, defined as the callus tissue volume, exclusive voids, e.g. pores and 
gaps; 
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- Volumetric Bone/Implant contact VBIC (%,); defined as the ratio between the area 
of the bone graft (implant) in the direct contact with the surrounding bone and the 
total area of the graft. 
In addition, 3D models of the samples inside the VOI were created in order to assess 
three-dimensionally the quality of the treatments. 
 
 
 
4.5 HISTOLOGY AND IMMUNOHISTOCHEMISTRY 
 
 
4.5.1 Histological processing of forearm bone samples 
 
 
Left and right forearm bone segments were harvested from each rabbits and processed 
for paraffin embedding. More in details, samples were fixed in 10% neutral buffered 
formalin (Sigma-Aldrich, Saint Louis, Missouri, USA) for at least 24 hours at room 
temperature. After rinsing in running tap water, samples were decalcified in 5% solution 
of formic (ACEF, Fiumicino, Rome, Italy) and nitric acid (Sigma-Aldrich, Saint Louis, 
Missouri, USA) for 20 days at 37°C and then extensively rinsed in distilled water. Each 
radius was cut along the major axis to help the inclusion and dehydrated in increasing 
ethanol solutions (Panreac AppliChem, Barcelona, Spain) for 1 hours each (70%, 95% 
twice, 100% twice), to remove the aqueous component and facilitate the penetration of 
the embedding medium, and defatted in xylene (VWR International, Milan, Italy). After 
overnight infiltration in liquid wax (56°C), samples were finally embedded in paraffin 
(Sigma-Aldrich, Saint Louis, Missouri, USA). From tissue blocks, thin histological 
section (5 μm thick) were obtained by a semi-automated microtome (MicromH340E, 
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Germany) and stained with Haematoxylin (Sigma-Aldrich, Saint Louis, Missouri, USA) 
and Eosin (Bio-Optica, Milan, Italy) (H/E). Images of each section were acquired with 
digital scanner at different magnification.  
 
 
4.5.2 Immunohistochemical tests on forearm bone samples 
 
 
Three slides from each specimen were selected to be tested for Vascular Endothelia 
Growth Factor (VEGF), Slices were dewaxed with consecutive steps in xylene and in 
decreasing graded ethanol solutions (5 minutes each) until PBS rinsing for 10 min. After 
permeabilization by incubation in 0.3 % hydrogen peroxide in PBS solution for 15 min, 
slides were pre-treated for antigen unmasking with 0.2 % Pronase (Sigma-Aldrich, Saint 
Louis, US-MO) solution in PBS for 30 min at 37 °C. After washing, the slides were 
incubated at room temperature for 1 hour with Blocking Serum (Vectastain Universal 
Quick Kit, Vectors Laboratories, Burlingame, US-CA) in order to prevent nonspecific 
bindings, then incubated overnight at 4 °C with specific rabbit polyclonal antibody 
against VEGF (Novus Biologicals, Littleton, US-CO), at a concentration of 1:100. After 
rinsing in PBS, slides were incubated with a universal HRP-conjugated secondary 
antibody and Streptavidin/Peroxidase complex (VECTASTAIN® Universal Quick Kit 
Concentrate). The reactions were finally developed using Vector NovaRed Substrate Kit 
for Peroxidase (Vectors Laboratories, Burlingame, US-CA). 
As negative controls slides treated omitting the primary antibody were used, in order to 
check proper specificity and performance of the applied reagents. 
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4.5.3 Histological processing of chondrogenic micromasses and BIOPAD® seeded 
scaffolds with rBMSC 
 
At the end of in vitro tests experimental time, micromasses and BIOPAD® seeded 
scaffolds were fixed in 10% neutral buffered formalin for 30 min, washed in distilled 
water and dehydrated in graded ethanol series 30 minutes for each steps. Finally, they 
were embedded in paraffin and the obtained blocks sectioned in the trasversal plane. A 
series of 5 µm section were obtained and analyzed for histology after staining with 
Hematoxylin-Eosin to appreciate cellularity and extracellular matrix organization of 
micromasses and the scaffold seeding and cells distribution for BIOPAD® seeded 
scaffolds.  
 
 
4.6 STATISTICAL ANALYSIS  
 
 
Statistical analysis was performed using the IBM® SPSS® Statistics v.23 software.  The 
tested hypotheses were: (1) the presence of bone grafts is able to improve the healing of 
the critical size defect realized into the radio in comparison to untreated; (2) the 
deviation of vascular axis inside the medullary cavity of bone graft increased the healing 
process in comparison to bone graft alone; and (3) what is the advantage to add a 
collagen based scaffold over the bone graft with vascular axis inside.  After having 
verified that data did not present a normal distribution (Kolmogorov Smirnov test), the 
Student’s t test was used to compare data by creating 15,000 bootstrap samples from the 
entire data set and repeating the estimation process. Bias corrected and accelerated 
(BCa) 95% confidence intervals (CI) were obtained using bootstrap method of the 
corresponding sampling distributions. Data are reported as Mean, BCa 95% CI at a one 
tailed p-value < 0.05. 
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CHAPTER 5 
RESULTS 
 
 
 
5.1 MACROSCOPIC ASSESSMENT 
 
 
All the treated animals reached the expected experimental times without any clinical 
complications.  
Mascroscopic evaluations did not highlight any evidence of inflammation, infection, 
hematoma, edema or reaction in the tissues surrounding the radius.  
The native structure and architecture of the bone around the implant appeared preserved, 
as well as the adjacent segment of ulna. The surgical procedure for the insertion of bone 
graft did not alter the physiological structure of the anatomical region. In some cases, the 
formation of a synostosis between radio and ulna was noted.     
The integration of the graft at both the extremities of the defect was still incomplete, 
however the graft remained generally in place even though in some cases it was not 
completely aligned.  
Mostly at the experimental time of 8 weeks, contact areas between the graft and the 
surrounding bone can be observed.  
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5.2 CELL CULTURES, RABBIT BONE MESENCHYMAL STEM CELLS (RBMSC) 
CHARACTERIZATION AND SCAFFOLD SEEDING 
 
All the rBMSC samples demonstrated the ability to give rise to adipocytes, chondrocytes 
and osteoblasts (Fig. 11). The rBMSC cultures differentiating to adipocytes showed an 
intracellular accumulation of lipid droplet (Fig. 11 a,b); those to chondrocytes, under 
micromass conditions, presented GAG deposition and cellular organization in the typical 
matrix lacunae (Fig. 11 c,d); and those to osteogenic displayed the typical mineralization 
nodules (Fig. 11 e,f).  
Furthermore, the biochemical evaluation performed by DMMB method confirmed a 
significant (p < 0.05) higher amount of GAG in the matrix of the micromasses 
maintained in CM (2565 ng, 356-5013) in respect than those grown in BM (125 ng, 68-
181). The osteogenic differentiation was partially confirmed by the synthesis of ALP 
that showed a significant higher production of intracellular ALP in OM than BM after 7 
(OM: 138.4µmol, 98.5 – 178.4; BM: 52.7µmol, 47.3 – 68.2; p< 0.05) and 14 (OM: 116 
µmol, 92 - 143; BM: 87 µmol,58 - 112; p =0.09) days of cultures. The Alizarin Red 
histochemical staining followed by cetylpyridinium quantification detected the calcium 
deposition (ref. Y. D-C Halvorsen, Tissue Engineering, 2001), that resulted higher (p< 
0.05) in the OM (297 nmol, 130-502) than BM (97 nmol, 57-147) after 28 days of 
culture.  
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Figure 11   Trilineages differentiation of BMSC cultures. a,b (magn. 40x): adipogenic differentiation. Evident 
lipid droplets after 2 weeks of cultures.  c,d (magn. 20x): condrogenic differentiation. Histological images of 
micromass sections after 1 month of culture. e,f (magn.10x, 4x): osteogenic differentiation. Alizarin Red 
staining for the evaluation of calcium-rich deposits after 2 weeks of culture.   
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By means of RT-PCR was evaluated the expression of the main genes of the osteoblast 
differentiation (Fig. 12). Col1a1 and Alpl were significantly (p < 0.05) upregulated at 14 
days in comparison to the other experimental times. On the contrary, Il1a was 
significantly down regulated after 24 hours (p < 0.005). 
In order to observe in vitro the adhesion ability of rBMSC to the biomaterial employed 
in vivo, fluorescent staining was used. Qualitative results showed a great cell density on 
the scaffold surface, but it has been possible to appreciate also the cell infiltration inside 
the first thickness layers. Thanks to the differential staining, it was possible to 
distinguish live and dead cells, and to note that the totality of cells was alive, spread and 
organized at 24 hours such as at 2 weeks. Results were supported by histological 
analysis, which showed the distribution of cells all inside the material (Fig. 13).  
Finally, the cocultures obtained by seeding rBMSC on the scaffold in presence of rEC 
on the same well bottom revealed a positive influence of the endothelial cells on the 
rBMSC proliferation (Fig. 14). This evaluation with fluorescent staining showed in fact 
an increase in the number of the mesenchymal cells when stimulated by rEC in 
comparison to cell cultured alone.   
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Figure 12  Gene expression results of Col1a1 (A), Alpl (B), Il1a (C). Non parametric Student t test 
(bootstrap) (a, p < 0.05): 14 days versus other experimental time points for Col1a1 (a), Alpl (b); 1 days 
versus other experimental time points for Il1a. 
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Figure 13  Scaffold colonization by BMSCs labeled with fluorescent LIVE/DEAD® staining at 24h 
(a,b,c), 1 week (d,e,f) and 2 weeks (g,h,i), and histological images of seeded scaffold stained with 
Hematoxylin/Eosin at 24h (j), 1 week (k) and 2 weeks (l). Magn. 4x (a,b,d,e,g,h) 5x (j), 10x (c,f,k), and 20x 
(l).  
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Figure 14 Scaffold colonization by BMSCs labeled with fluorescent LIVE/DEAD® staining at 1 week 
(a,b), and 2 weeks (c,d,e,f). Imagines of scaffold seeded with rBMSCs in absence (a,c,e), or presence 
(b,d,f) of HUVEC on the well bottom. Magn. 4x (a,b) and 10x (c,d,e,f).  
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5.3 X-RAY AND MICROCT 
 
 
X Rays showed a good positioning of the implants, with macroscopic signs of 
integration in the experimental groups at 4 and 8 weeks of follow up (Fig.15). 
 
 
 
 
Figure 15  X rays at the explant time of 8 weeks, experimental group. 
 
 
Microtomography analysis (Fig. 16) showed that the main differences were related to the 
experimental times and to the use of rBMSC. The contribution of the vascular axis 
deviation within the defect may be highlighted by a greater tendency to bone graft and 
native cortical bone remodeling activities over time.  
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Figure 16   3D representative models of samples analysed with micro-CT. 
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Measured parameters highlighted that Callus density, Cl.V/TV was higher in radii treated 
with bone graft and vascular axis deviation or with bone graft alone in comparison to the 
other treatments, but in radii treated with bone graft alone Cl.V/TV decreased 
significantly (p < 0.05) in comparison to those treated with bone graft and vascular axis 
deviation (Figure 17a). Callus Index (Cl.Ind) decreased significantly (p < 0.005) in radii 
treated with bone graft and vascular axis deviation in comparison to those treated with 
bone graft at 8 weeks, as well as (p < 0.005) in those treated with bone graft with 
vascular axis deviation and BIOPAD® scaffold seeded with rBMSC in comparison to 
those treated with bone graft with vascular axis deviation at 4 weeks (Figure 17b). 
Volumetric Bone/Implant contact (VBIC) increased (p < 0.05) in radii treated with bone 
graft with vascular axis deviation in comparison to those treated with bone graft at the 
longest experimental time (Figure 17c). 
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Figure 17 Micro-CT quantitative 3D analysis (Mean, BCa 95% CI). A) results relative to Callus 
density Cl.V/TV: Bone graft and Vascular axis deviation group versus Bone graft group at 8 weeks (a, p < 
0.05); B) results relative to Callus Index Cl.Ind: Bone graft, Vascular axis deviation and BMC group 
versus Bone graft and Vascular axis deviation group at 4 weeks (a, p < 0.005) and Bone graft and 
Vascular axis deviation group versus Bone graft group at 8 weeks (b, p < 0.005); C) results relative to 
Volumetric Bone/Implant contact VBIC: Bone graft, Vascular axis deviation and BMC group versus Bone 
graft and Vascular axis deviation group (a, p < 0.05). 
 
 
 
 
5.4 HISTOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSIS OF RADIUS  
 
 
All animals treated reached the end of the expected experimental time without any 
clinical complications or evidence of lamness during all experimental time; recovery 
from surgery was rapid and all animals were able to feed and walk normally in an hour. 
Macroscopic evaluations did not highlight any evidence of inflammation, infection, 
hematoma, oedema or reaction in the tissues surrounding the radius.  
The native structure and architecture of the bone around the implant appeared preserved, 
as the adjacent segment of ulna, and the surgical procedure for the insertion of bone 
graft did not altered the physiological structure of the anatomic region. In some cases, 
the formation of a synostosis between radio and ulna was noted (Fig. 18).     
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Figure 18 Presence of synostosis between radio and ulna. Hematoxylin/Eosin staining; 2 x 
magnification. 
 
 
 
The integration of the graft at both the extremities of the defect appeared still 
incomplete, the graft was observed generally in place even though not completely 
aligned in some specimens.  
At the longer experimental time (8 weeks), in the samples, which underwent surgery of 
vascular deviation with and without rBMSC, some contact areas of the graft in 
continuity with surrounding bone can be observed. In the contact fissure at the interface 
between graft and bone it can be appreciated the presence of monolayer of osteoblasts 
on the trabeculae, lacunae filled with osteocytes and vessels (Fig.19). 
The onset of phenomenon of endochondral ossification seemed to be present in the areas 
of incomplete osteointegration, between graft and bone (Fig.20). 
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                                                                                                                                        b 
Figure 19 Detail of integration of graft to bone (a) and layer of osteoblasts on the trabeculae at the 
interface between bone and graft (b).  
Hematoxylin/Eosin staining; 5x and 10 x magnification. 
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It can be appreciated the presence of cartilagineous tissue, underlined by the less bright 
staining, at the interface between bone and graft, proceeding from the innermost 
extremities of the native bone, with zones of proliferation containing flattened 
chondrocytes in clusters or oriented in almost a columnar shape, interspersed in the 
territorial matrix (Fig. 21).  
 
 
 
 
 
Figure 20 Endochondral ossification at the interface between bone and graft.  
Hematoxylin/Eosin staining; 5x and 10 x magnification. 
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Figure 21  Cartilagineous tissue at the interface between bone and graft, proceeding from the innermost 
extremities of the native bone, with zones of proliferation containing flattened chondrocytes in clusters or 
oriented in almost a columnar shape.   
Hematoxylin/Eosin staining; 5x and 10 x magnification. 
 
 
 
As far as the groups left untreated or underwent graft alone surgery, two major trends 
were found: in some cases the bone graft appeared completely not integrated (Fig. 22 a), 
without any signs of beginning of remodeling, aimed at the integration of the graft with 
the rest of the segment; in other samples the extremities of the graft appeared merged to 
form a synostosis, which does not match the normal physiology of the radius (Fig. 22 b).  
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 a  b  
 
 
Figure 22 Failed integration between bone and graft (a) and synostosis between  ossification at the 
interface between the extremities of the graft (b).  
Hematoxylin/Eosin staining;10 x magnification. 
 
 
 
 
 
Immunohistochemistry qualitative evaluations of VEGF staining showed a greater 
antibody positivity in the samples treated with the vascular axis deviation, in which was 
observed in particular the area of interface between bone and graft. The samples that 
were not subjected to axis deviation showed instead a milder reactivity to VEGF (Figure 
23).  
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Figure 23 Images of VEGF immunohistochemical staining in vascular deviation axis group (a,b) 
and control groups (c,d).  
10 x magnification. 
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CHAPTER 6 
DISCUSSION 
 
 
The repair of long bone defects represents a challenge for the orthopaedic surgeons, with 
multiple described techniques that offer positive aspects but also carry out strong 
drawbacks. The allograft substitution is nowadays the most frequently performed 
surgery in this occurrences, offering the benefits to provide a material which is already 
perfectly organized in its structure and even without cellular component, it represents an 
optimal scaffold for the patient to be colonized. The conformation is optimal since the 
same skeletal districts are used as allograft, and the quantity of tissue to be transplanted 
is not limited. The potential risk of infective or transmissible diseases is strongly limited 
by the harvesting/storing protocols and the multiple controls on specimens of explanted 
tissue. Major drawbacks of this techniques are the limited amount of donors, the high 
costs for all the process and the ability of the host bone to colonize only one centimeter 
of the implanted allograft at both edges, resulting in an allograft which is composed only 
by mineralized tissue. After time, with the mechanical stresses of the regular life, the 
graft is often affected by small or massive fractures, which has no ability to heal since no 
osteoblast cellular component is present at its inside. Aim of the current project was to 
try to implement the graft colonization abilities of the patient. The basis of the idea was 
that there can be no graft colonization without angiogenesis: new vessels, built by the 
host in the contest of the implanted tissue, would deliver stem cells, nutritive substances 
and all the regenerative network useful for the graft colonization. The neoangiogenesis 
require a main vessel to start from, so the original idea was to make a microsurgical 
anastomosis with a vessel passing into the cylindrical graft. the small size of the animal 
model and other technical limitation led us to the idea of inserting a vascular bundle in 
the graft without cutting and re-suturing it. The median bundle in the rabbit forearm is 
particularly easy to find and it is close to the radial shaft: it represents an optimal 
anatomical location in a good animal model for this purpose.  
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No issues arose in the course of the surgery: the opportunity to avoid the use of 
microvascular sutures helped in keeping the procedure simple and rapid. The fixation of 
the raft represented the most demanding step during the procedure: in cases of vascular 
bundle deviation in the graft the cylinder was not strong enough to be positioned press 
fit so a secure fixation was required, whether with 2 polysorb stitches or metallic 
circlages.  
At explant times the first main goal of the procedure was achieved: no signs of 
inflammation, infection, edema, neurovascular deficiency were observed in any animal, 
so the whole procedure, in all the experimental variants, can be considered safe. All the 
performed steps were performed in good aseptic condition, the storing protocols were 
safe, and all the implanted material were not contaminated as well. The integration of 
the graft with the surrounding bone was more evident with the increasing follow up 
time, mostly at 8 weeks: this indicates that probably 2 and 4 weeks are not sufficient to 
see a good graft integration process, and the experimental times should have been 
prolonged to 12 and 16 weeks. The occasional synostosis formation between ulna and 
radius can be explained with an excess of regenerative process in a district with a very 
limited movement activity, since rabbits have no pronosupination and a synostosis 
between the two forearm bones is sometimes naturally present. 
The cell cultures and expansion provided additional essential informations: all the 
rBMSC are able to differentiate in adipogenic, chondrogenic and osteogenic cell 
lineages in appropriate environments expressing marker and genes typical of the specific 
lineage. This indicates that these cells are extremely active with a strong plasticity, a key 
feature for the experiment. Most important it is the osteogenic capability of these cells, 
highly indicated by the high expression of genes typical of the differentiation towards 
this lineage.  
The analysis of the cell culture on the collagenic scaffold pointed out that the cells are 
highly represented in the biomaterial and are distributed in the whole contest of the 
scaffold itself and not only on the surface, indicating a good tolerability of the collagen 
scaffold for these type of stem cells. Furthermore, as support of this factor, the 
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LIVE&DEAD assessment showed that the totality of cells was alive, spread and 
organized at 24 hours and at 2 weeks after the seeding. 
The micro-CT analysis was assessed in order to evaluate the increased remodeling 
activity of the bone (graft or host) and the efficacy of the vascular deviation. The Callus 
density was higher in specimens treated with bone graft and vascular axis deviation or 
with bone graft alone in comparison to the empty controls.  In radii treated with bone 
graft alone the Callus density decreased over time in comparison to those treated with 
bone graft and vascular axis deviation. This may indicate that in the bone graft alone 
group there is a higher remodeling of the graft as consequence of the regular biologic 
processes, while in the second group the callus density decreases slower due to the new 
bone synthesis promoted by the cellular component provided by the vascular bundle 
deviation.  
The Callus Index decreased significantly in radii treated with bone graft with vascular 
axis deviation as well as in those treated with bone graft with vascular axis deviation and 
BIOPAD® scaffold seeded with rBMSC in comparison to those treated with bone graft 
with vascular axis deviation. 
Another important aspect is that the Volumetric Bone/Implant contact significantly 
increased in radii treated with bone graft with vascular axis deviation in comparison to 
those treated with bone graft at the longest experimental time: this support the idea that 
the vascular bundle may provide a supplement of cells with regenerative capabilities. 
Histology seemed to confirm the trend observed with microCT results, showing clear 
signs of ossification and integration of the graft to the surrounding bone, with a high 
presence of vessels, as indicated also by immunohistochemical analysis. The incomplete 
integration can be considered so consequence of the short experimental time; in fact, the 
evidence of endochondral ossification suggests that at longer experimental times a 
greater osteointegration might be appreciated.  In addition, a However, the vascular axis 
deviation seemed to ha exerted a trophic effect, increasing the presence of vessel and 
stimulating bone metabolism.  
The influence of the biomaterial supplement to this procedure (BIOPAD® scaffold plus 
concentrated bone marrow cells) is unclear in this evaluation even if associated with a 
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better outcome: the trophic effects of vascular deviation, in fact, have probably 
overlapped the influence of material and rBMSCs, making difficult to assess if there was 
a synergistic effect and to what extent.  
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CHAPTER 7 
CONCLUSIONS 
 
 
As expected, the obtained results showed that the critical size defect was not completely 
healed at the described experimental time. Nevertheless, the experimental groups with 
vascular axis deviation showed a higher neoangiogenic activity and bone turnover, lay 
the foundation for an active integration of the bone graft. In vitro tests suggested that the 
rBMSC supplement with collagen biomaterial might be effective in terms of repair 
process stimulation. rBMSC cells showed pluripotent abilities and a proliferation 
increment in presence of endothelial cells.  
As collateral observation, the animal model set up for this study showed to be a good 
model for critical size defect and critical size defect restoration, with the note that the 
experimental time should not stop at 8 weeks, but should be continued at least up to 12 
weeks. In addition, a more effective stabilization of the graft should be investigated, in 
order to mimic the clinical post surgical condition, that facilitates the maintenance in 
place and the integration of the graft. 
The future perspective for this study is to be confirmed with longer follow up and 
possibly in larger animal models (sheep for example) before step up to humans. Another 
interesting development could be to test different bone substitutes with the same 
procedure, and to compare them to the healing abilities of the bony allograft. In case of 
positive results, it would be extremely positive to combine the pros of a bone substitute, 
which eliminates the cons of allografting, with a vascular procedure, which eliminates 
the major cons of the bony substitute like the non osteointegration and substitution.  
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